Skip to main content
 

AHA Innovators’ Network Member Accurkardia Publishes First Study Showcasing the Clinical Value of its AccurBeat Platform

AHA Innovators’ Network Member Accurkardia Publishes First Study Showcasing the Clinical Value of its AccurBeat Platform

AHA Innovators’ Network member AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the clinical value of its AccurBeat platform. AccurBeat is AccurKardia’s platform for analysis of 30-seconds ECGs generated by wearable devices. The full study, conducted in collaboration by HITLAB (Healthcare Innovation & Technology Lab) and SUNY Downstate at JMIR Publications.

Read more here

More News

  • Member company Accukardia selected as Quarterfinalist for 2023 Digital Health Hub Foundation Rising Star Award

  • AliveCor Featured in Business Insider’s most promising start ups of 2024

  • CHTI Member Hello Heart Publishes Study in the Journal of the American Heart Association on Mobile Health Tech and Significant Reductions in BP, Cholesterol and Weight